YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Leading industry experts will come together for multi-day conference to discuss how advancements in AI-driven automation, agentic AI, and data analytics will accelerate clinical trials BOSTON, October 08, 2026--(BUSINESS WIRE)--eClinical S…
Moderna MRNA shares are set to join the Nasdaq-100 Index on Oct. 9, marking another milestone for the biotech after its sharp gains this year. The company will replace Warner Bros. Discovery in the index before the opening bell on Friday.…
Constellation Brands, Inc. (STZ) shares rose 2.4% after the company reported second quarter fiscal 2027 revenues of $2.63 billion, surpassing the Zacks Consensus Estimate by 2.46%. Penguin Solutions, Inc. (PENG) shares surged 13.1% after t…
The Morning Bull - US Market Morning Update Thursday, Oct, 8 2026 US Market stock futures are essentially flat, with E-mini S&P 500 contracts edging up only fractionally as investors weigh strong demand for imported goods against early sig…
On October 1, Jim Cramer highlighted Constellation Energy Corporation (NASDAQ:CEG) and Vistra Corp. (NYSE:VST) during Mad Money, pointing to their share-price declines and demand for nuclear electricity, as he said: You could go with the n…
Tempus, a medical testing and healthcare tech company, has partnered with industry giants like Merck and Moderna to revolutionize healthcare. Founder and chief executive Eric Lefkofsky discusses these partnerships, Tempus's financial strat…
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Jess Menton, Carol Massar and Lisa Mateo. Video Transcript 00:00 Scarlet Fu We're about two minutes away…
Collaboration to Support Potential Commercialization of Intismeran Autogene CHICAGO, October 07, 2026--(BUSINESS WIRE)--Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization o…
Investing.com - U.S. stock futures pointed lower on Wednesday ahead of the release of key minutes from the Federal Reserve's latest policy gathering, as investors looked for clues on the central bank's interest-rate outlook. Before you buy…
The S&P 500 hit a high as the stock market extended a win streak. Astera Labs, GE Vernova and Arista Networks led AI stock buys. Continue Reading
The Morning Bull - US Market Morning Update Wednesday, Oct, 7 2026 US stock futures are pointing higher this morning, with key contracts on the S&P 500 and Nasdaq up around 0.2% to 0.6% as investors digest strong service sector readings an…
Moderna (MRNA) appointed former executive Juan Andres as its new Chief Operating Officer in a newly created role, giving investors additional information to weigh against a sharp recent move in the stock. Recent trading has been choppy for…
The death of a Russian lab technician triggers fears of a pneumonic plague outbreak, even as health officials downplay the risk. Continue Reading
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Sally Bakewell, Carol Massar and Jess Menton. Video Transcript 00:00 Romaine And right now, we are t…
The S&P 500 hit a high as the stock market extended a win streak. Astera Labs, GE Vernova and Arista Networks led AI stock buys. Continue Reading
Novavax stock (NVAX) fell on Tuesday after a World Health Organization (WHO) spokesperson told reporters that there was a "low" risk of a plague epidemic, after a 28-year-old woman who worked in a Russian anti-plague laboratory died last w…
Biotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses. Continue Reading
Merck's MRK stock has declined 7.2% in a month. Investors are looking at this correction as a pullback after a strong run rather than a deterioration in its core business. The stock has surged roughly 60% over the past year. It also reache…
The 8:30 Hosts Julie Hyman, Pras Subramanian, and Jake Conley outline trending stories to watch on Tuesday: AMD (AMD) CEO Lisa Su's recent comments, Paramount's (PSKY) deal with Warner Bros. (WBD) finally closing, Moderna (MRNA) and other…
The 8:30 Hosts Julie Hyman, Pras Subramanian, and Jake Conley outline trending stories to watch on Tuesday: AMD (AMD) CEO Lisa Su's recent comments, Paramount's (PSKY) deal with Warner Bros. (WBD) finally closing, Moderna (MRNA) and other…
Available from October 6, 2026, the 12 stocks and 8 ETFs extend STARTRADER's round-the-clock access across South Korea, Hong Kong and the US. PORT LOUIS, Mauritius, Oct. 06, 2026 (GLOBE NEWSWIRE) -- STARTRADER has launched 20 new Stock and…
Parker-Hannifin Corporation (NYSE:PH) is not attractive simply because it is a large industrial company. What really sets it apart is the kind of products it makes and the role those products play for customers. Its components are often sm…
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test across harder-to-treat solid tumors. The…
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on November 1, 2006. Passivel…
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Luckily f…
Moderna Inc. (NASDAQ:MRNA) ranked as the second top-performing stock in the US market in the third quarter of the year, with the surge primarily driven by rosy growth prospects from its combined therapy candidate for treating the most comm…
Mentioning how the FDA advisory panel backed its Galleri multi-cancer early detection test, a caller asked for Jim Cramer's opinion on GRAIL, Inc. (NASDAQ:GRAL) during the lightning round of the September 30 episode of Mad Money. He replie…
[View of Moderna office entrance with logo sign, Biotechnology industry] Veronique D Shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) have rallied 202% since Aug. 18, fueled by positive news about the biotech company's exper…
Wall Street closed in the green on Friday after the September nonfarm payrolls report came in cooler than economists expected. The blue-chip Dow ended up 0.5%, the benchmark S&P 500 gained 0.7%, and the tech-focused Nasdaq Composite advanc…
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) f…
The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) closed in the green on Friday, after the week saw latest payroll data and ea…
Moderna (NasdaqGS:MRNA) appointed Juan Andres as its first Chief Operating Officer as it reshapes its leadership structure. The new COO role focuses on scaling manufacturing for Moderna's personalized cancer vaccine and wider oncology pipe…
Nvidia stock is on pace to close at a record high. Continue Reading
Investing.com - U.S. stock index futures rose on Friday, as investors prepared for the release of key payrolls data that could offer fresh insight into the health of the economy and the outlook for interest rates. Before you buy NVIDIA: ou…
Nike slumps after the retailer misses analysts’ first-quarter earnings target and issues downbeat fiscal-year guidance. Continue Reading
The entertainment company will exit the Nasdaq after it completes its merger with Paramount Skydance. Continue Reading